Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14

Deprecated: Function jetpack_form_register_pattern is deprecated since version jetpack-13.4! Use Automattic\Jetpack\Forms\ContactForm\Util::register_pattern instead. in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 6078
Canon plans $3.5bn buying spree in medical and security ops - The Pharma Times | Pharma & Health Care News Portal

Canon plans $3.5bn buying spree in medical and security ops

Japanese technology group will seek out drivers of future growth

Tokyo, January 08, 2018: Canon is putting its ample cash on hand to work by spending up to 400 billion yen ($3.53 billion) on acquisitions over the next three years to beef up its medical and security segments.

The Japanese technology group aims to take in 1.5 trillion yen in sales from new business operations by 2020, Chairman and CEO Fujio Mitarai told The Nikkei on Friday.

Canon’s biggest takeover so far is the 2016 acquisition of Toshiba Medical Systems from the Toshiba group. But apart from that, Canon in effect invested around 400 billion yen in new businesses over nine years. Moving forward, the company will explore the same level of expenditures in just one third of the time.

Targets in the buyout spree will include corporations possessing technologies, services and talents that complement previous acquisitions. For the medical segment, positioned as a strong growth sector, Canon will concentrate heavily on acquiring assets strong in related information-technology services according to asia.nikkei.com.

Canon is setting its sights on earning 5 trillion yen in group sales in 2020. New businesses will account for up to 30% of the total, an increase from 24% currently.

The group estimates free cash flow reached 330 billion yen for the full year ended December 2017. Canon now has 640 billion yen in cash and cash equivalents, which would give it ample room to embark on 400 billion yen in spending.

The market for cameras and office equipment is showing signs of recovery, but no significant growth is expected in the long run. Canon, which used to focus more on in-house research and development, responded to the warning signs by switching gears to developing future growth engines.

Asia.nikkei.com further added that canon is also establishing a large Silicon Valley R&D hub this year, which will be an expansion of the software R&D laboratory already at the U.S. location. The site will also serve as the center of a data-collecting operation that will be used to acquire the best-suited Silicon Valley startups and talents.

The Pharma Times News Bureau

Recent Posts

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

9 hours ago

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

1 week ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

1 week ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago